3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline

C84H98I2N26O5 — CID 167608543

IUPAC3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline
SMILESC.Cc1cnc2c(I)nn(C3CCCCO3)c2n1.Cc1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2n1.Cc1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2n1.Cc1cnc2c(n1)CN=C2I.O=c1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2[nH]1.c1cnc2c(c1)CCCC2
InChIInChI=1S/2C19H22N6O.C18H20N6O2.C11H13IN4O.C9H11N.C7H6IN3.CH4/c2*1-13-12-21-17-18(22-13)25(16-8-2-3-11-26-16)23-19(17)24-10-5-6-14-15(24)7-4-9-20-14;25-14-11-20-16-17(21-14)24(15-7-1-2-10-26-15)22-18(16)23-9-4-5-12-13(23)6-3-8-19-12;1-7-6-13-9-10(12)15-16(11(9)14-7)8-4-2-3-5-17-8;1-2-6-9-8(4-1)5-3-7-10-9;1-4-2-9-6-5(11-4)3-10-7(6)8;/h2*4,7,9,12,16H,2-3,5-6,8,10-11H2,1H3;3,6,8,11,15H,1-2,4-5,7,9-10H2,(H,21,25);6,8H,2-5H2,1H3;3,5,7H,1-2,4,6H2;2H,3H2,1H3;1H4
InChIKeyKSHQNBQAOONARV-UHFFFAOYSA-N
MW1805.69 g/mol
LogP15.44
Rot. Bonds7

About 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline

3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline (PubChem CID 167608543) has the molecular formula C84H98I2N26O5 and a molecular weight of 1805.69 g/mol. Its IUPAC name is 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline.

Molecular Properties

Compound Name3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline
PubChem CID167608543
Molecular FormulaC84H98I2N26O5
Molecular Weight1805.69 g/mol
Exact Mass1804.63
IUPAC Name3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline
SMILESC.Cc1cnc2c(I)nn(C3CCCCO3)c2n1.Cc1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2n1.Cc1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2n1.Cc1cnc2c(n1)CN=C2I.O=c1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2[nH]1.c1cnc2c(c1)CCCC2
InChIInChI=1S/2C19H22N6O.C18H20N6O2.C11H13IN4O.C9H11N.C7H6IN3.CH4/c2*1-13-12-21-17-18(22-13)25(16-8-2-3-11-26-16)23-19(17)24-10-5-6-14-15(24)7-4-9-20-14;25-14-11-20-16-17(21-14)24(15-7-1-2-10-26-15)22-18(16)23-9-4-5-12-13(23)6-3-8-19-12;1-7-6-13-9-10(12)15-16(11(9)14-7)8-4-2-3-5-17-8;1-2-6-9-8(4-1)5-3-7-10-9;1-4-2-9-6-5(11-4)3-10-7(6)8;/h2*4,7,9,12,16H,2-3,5-6,8,10-11H2,1H3;3,6,8,11,15H,1-2,4-5,7,9-10H2,(H,21,25);6,8H,2-5H2,1H3;3,5,7H,1-2,4,6H2;2H,3H2,1H3;1H4
InChIKeyKSHQNBQAOONARV-UHFFFAOYSA-N
XLogP15.44
TPSA330.71 Ų
H-Bond Donors1
H-Bond Acceptors30
Rotatable Bonds7
Heavy Atoms117
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001805.69
LogP ≤ 515.44
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline?
The IUPAC name of 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline (CID 167608543) is 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline.
What is the SMILES notation for 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline?
The canonical SMILES for 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline is C.Cc1cnc2c(I)nn(C3CCCCO3)c2n1.Cc1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2n1.Cc1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2n1.Cc1cnc2c(n1)CN=C2I.O=c1cnc2c(N3CCCc4ncccc43)nn(C3CCCCO3)c2[nH]1.c1cnc2c(c1)CCCC2.
What is the InChIKey of 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline?
The InChIKey is KSHQNBQAOONARV-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H22N6O.C18H20N6O2.C11H13IN4O.C9H11N.C7H6IN3.CH4/c2*1-13-12-21-17-18(22-13)25(16-8-2-3-11-26-16)23-19(17)24-10-5-6-14-15(24)7-4-9-20-14;25-14-11-20-16-17(21-14)24(15-7-1-2-10-26-15)22-18(16)23-9-4-5-12-13(23)6-3-8-19-12;1-7-6-13-9-10(12)15-16(11(9)14-7)8-4-2-3-5-17-8;1-2-6-9-8(4-1)5-3-7-10-9;1-4-2-9-6-5(11-4)3-10-7(6)8;/h2*4,7,9,12,16H,2-3,5-6,8,10-11H2,1H3;3,6,8,11,15H,1-2,4-5,7,9-10H2,(H,21,25);6,8H,2-5H2,1H3;3,5,7H,1-2,4,6H2;2H,3H2,1H3;1H4.
What are the key properties of 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline?
3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline has a molecular weight of 1805.69 g/mol, XLogP of 15.44, 7 rotatable bonds, 1 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)-7H-pyrazolo[4,5-b]pyrazin-6-one;3-iodo-6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazine;7-iodo-3-methyl-5H-pyrrolo[3,4-b]pyrazine;methane;bis(1-[6-methyl-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-3-yl]-3,4-dihydro-2H-1,5-naphthyridine);5,6,7,8-tetrahydroquinoline is sourced from PubChem (CID 167608543), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).